Mode
Text Size
Log in / Sign up
N/A N=166 Randomized Prevention

Reduction of Sitting Time: Sedentarism Intervention Trial

Life Style · Physical Activity · Sedentary Behavior

Enrolled (actual)
166
Serious AEs
0.0%
Results posted
Jan 2015
Primary outcome: Primary: Change in Objectively Measured Sitting Time From Baseline to 6 Months Follow-up — -0.27; 0.06 Hours per day

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Life style intervention (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Glostrup University Hospital, Copenhagen
Primary completion
Mar 2012

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Objectively Measured Sitting Time From Baseline to 6 Months Follow-up
-0.27; 0.06
SECONDARY
Change in High Density Lipoprotein (HDL) From Baseline to 6 Months Follow-up.
-0.03; -0.02

Summary

Recent studies have suggested that prolonged daily sitting time may in itself have a negative effect on health, even in people who engage in daily physical activity. The aim of the present study is to explore whether individually tailored lifestyle counselling aimed at reducing TV-viewing and other sedentary activities during leisure time and at work, can reduce sitting time and waist circumference, weight and blood pressure; and improve serum lipid levels. From a population-based health survey, 150 adult men and women with more than 3.5 hours of daily leisure time sitting time are recruited and randomly assigned to 1) an intervention group or 2) a control group. The intervention group will participate in 4 individually tailored lifestyle intervention sessions focussing on reduction of daily sitting time. The control group will receive no intervention.

Eligibility Criteria

Inclusion Criteria

  • Minimum selfreported 3 ½ hours of sedentary leisure time per day

Exclusion Criteria

  • More than 8 hours of vigorous activity per week
  • Physical handicap or illness that prevent reduction of sitting time
  • Must be able to read and understand Danish
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01221363). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search